PATENT CLAIM ANALYSIS

Application Number: 15912131
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "469000"]

Abstract:
Compositions and methods of treating depression infections are provided. More particularly, compositions including a combination of ketamine and a cytochrome p450 enzyme inhibitor are provided. Methods of using the compositions for treatment of depression, including treatment-resistant or treatment-refractory depression, are provided. Compositions and methods of treating depression infections are provided. More particularly, compositions including a combination of ketamine and a cytochrome p450 enzyme inhibitor are provided. Methods of using the compositions for treatment of depression, including treatment-resistant or treatment-refractory depression, are provided.

Claim (Index 3):
The composition according to  claim 2  wherein said depression is treatment-resistant or treatment-refractory depression.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 3.13333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13854648', '13287079', '13937985', '12919011', '12324507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7776563701445038
- 35 USC 102 Novelty (BERT): 0.5074178040377868
- Combined Prediction Score: 0.7506325135338321
- Mean Citation Score: 188.444828
- Max Citation Score: 193.4969
- Similarity Product: 110.93036648073198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test